Top compounds associated with response to SEC22C


Feature Type Standardized
Nominal ANOVA
mRNA austocystin d CTRPv2 pan-cancer AAC -0.19 2e-06
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.23 5e-05
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 8e-05
mRNA GW-2580 GDSC1000 pan-cancer AAC -0.14 8e-05
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.13 9e-05
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA neratinib CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
Download CSV